Related Experiment Video
Updated: May 21, 2025
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.2K
Changing Clinical Spectrum and Disease Progression in Young Patients With Bladder Cancer: A Retrospective
Mehul Agarwal1, Vikas Kumar Panwar1, Ankur Mittal1
1Urology, All India Institute of Medical Sciences, Rishikesh, Rishikesh, IND.
Cureus
|May 19, 2025
Summary
Young adults with bladder cancer face a more aggressive disease. Key risk factors include tobacco and chemical exposure, with high-grade tumors and recurrence being frequent, necessitating early detection and tailored surveillance.
Area of Science:
- Oncology
- Urology
Background:
- Bladder cancer is rare in young adults, with poorly defined disease course.
- Understanding clinical characteristics and risk factors in this demographic is crucial.
Purpose of the Study:
- Analyze clinical features, risk factors, progression, and survival in bladder cancer patients aged 40 or younger.
- Define the specific challenges and outcomes for young bladder cancer patients.
Main Methods:
- Retrospective review of 162 young bladder cancer patients (August 2017 - May 2024).
- Kaplan-Meier analysis for recurrence-free and overall survival.
Main Results:
- Predominantly male (85.2%), mean age 34.5 years.
- Tobacco use (49.4%) and chemical exposure (30.9%) were key risks.
- High-grade tumors (53.5% of NMIBC) and recurrence were frequent (mean RFS 3.7 years).
- Muscle-invasive bladder cancer (MIBC) patients had poorer survival (3.4 years) vs. NMIBC (6 years).
Conclusions:
- Young bladder cancer patients present with a more aggressive disease course.
- Early detection, targeted treatments, and tailored surveillance are vital due to unique risk factors and characteristics.
